Klaria Pharma Holding AB (publ.) (KLAR.ST)
SEK 0.29
(-8.63%)
SEK 0.29
(-8.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.2 Million | -49.72 Million | -24.79 Million | -35.29 Million | -14.79 Million | -9.12 Million |
| Net Income | -18.38 Million | -54.97 Million | -50.1 Million | -48.73 Million | -21.09 Million | -27.29 Million |
| Depreciation & Amortization | 9000.00 | 11.03 Million | 10.96 Million | 13.43 Million | 10.08 Million | 9.57 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.51 Million | 3.13 Million | 4.48 Million | 2.71 Million | -2.39 Million | 8.58 Million |
| Other non-cash items | -5.32 Million | -8.92 Million | 9.85 Million | -2.7 Million | -1.4 Million | 10.57 Million |
| Investing Cash Flow | -2000.00 | -42 Thousand | - | 13.05 Million | -387 Thousand | - |
| Investments in PPE | - | -42 Thousand | - | -33 Thousand | - | - |
| Acquisitions | - | - | - | 13.08 Million | -387 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 387 Thousand | - |
| Financing Cash Flow | 4.69 Million | 41.05 Million | 19.03 Million | 50.56 Million | 9.36 Million | -13 Thousand |
| Debt repayment | -11.11 Million | -678 Thousand | -20.04 Million | - | -10 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 16.31 Million | 41.73 Million | 38 Thousand | 50.56 Million | 10 Million | - |
| Other Financing Activities | -514 Thousand | -678 Thousand | 39.04 Million | 50.56 Million | 9.36 Million | -13 Thousand |
| Accounts receivables | 17.99 Million | -2.52 Million | -564 Thousand | -482 Thousand | 342 Thousand | -618 Thousand |
| Accounts payables | -2.99 Million | 5.65 Million | 5.05 Million | 3.19 Million | -2.73 Million | 9.2 Million |
| Inventory | - | -5.65 Million | -5.05 Million | -3.19 Million | 2.73 Million | - |
| Other working capital | 3.51 Million | 5.65 Million | 5.05 Million | 3.19 Million | -2.73 Million | 9.2 Million |
| Cash at beginning of period | 16.76 Million | 25.49 Million | 31.25 Million | 2.91 Million | 7.95 Million | 17.09 Million |
| Cash at end of period | 1.24 Million | 16.76 Million | 25.49 Million | 31.25 Million | 2.91 Million | 7.95 Million |
| Capital Expenditure | - | -42 Thousand | - | -33 Thousand | - | - |
| Effect of forex changes on cash | 1000.00 | -15 Thousand | -1000.00 | -19 Thousand | 774 Thousand | - |
| Net cash flow / Change in cash | -15.51 Million | -8.73 Million | -5.76 Million | 28.33 Million | -5.04 Million | -9.13 Million |
| Free Cash Flow | -20.2 Million | -49.77 Million | -24.79 Million | -35.32 Million | -14.79 Million | -9.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.24 Million | -7.11 Million | -18.38 Million | -7.85 Million | -10.8 Million | -10.11 Million |
| Depreciation & Amortization | 2000.00 | 2000.00 | 9000.00 | 3000.00 | 2.76 Million | 2.75 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.73 Million | 3.56 Million | 3.51 Million | 4.04 Million | 768 Thousand | 5.18 Million |
| Other non-cash items | 1.56 Million | -4.26 Million | -5.32 Million | 2.17 Million | 5.52 Million | 5.51 Million |
| Investing Cash Flow | - | - | -2000.00 | - | 24 Thousand | 1000.00 |
| Investments in PPE | - | - | - | - | - | 1000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 1000.00 |
| Financing Cash Flow | 1.49 Million | 7.5 Million | 4.69 Million | 594 Thousand | 684 Thousand | -2 Million |
| Debt repayment | -7.5 Million | -7.5 Million | -11.11 Million | -2.64 Million | -1.02 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1.14 Million | - | -2 Million |
| Common Stock Issuance | - | - | 16.31 Million | -1.19 Million | - | -2 Million |
| Other Financing Activities | -2000.00 | 2000.00 | -514 Thousand | -856 Thousand | 684 Thousand | 2 Million |
| Accounts receivables | - | - | 17.99 Million | 17.99 Million | - | - |
| Accounts payables | - | - | -2.99 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 4.73 Million | 3.56 Million | 3.51 Million | -4.91 Million | 768 Thousand | 5.18 Million |
| Cash at beginning of period | 937 Thousand | 1.24 Million | 16.76 Million | 2.28 Million | 8.86 Million | 13.05 Million |
| Cash at end of period | 496 Thousand | 937 Thousand | 1.24 Million | 1.24 Million | 2.28 Million | 8.86 Million |
| Capital Expenditure | - | - | - | - | - | 1000.00 |
| Effect of forex changes on cash | - | - | 1000.00 | -11 Thousand | -12 Thousand | -24 Thousand |
| Net cash flow / Change in cash | -441 Thousand | -310 Thousand | -15.51 Million | -1.03 Million | -6.58 Million | -4.19 Million |
| Free Cash Flow | -1.93 Million | -7.81 Million | -20.2 Million | -1.63 Million | -7.27 Million | -2.16 Million |
INR
ZNOG
688508
0298
900140
ARWYF